Literature DB >> 6499265

The fragile X syndrome. A study of 83 families.

J P Fryns.   

Abstract

The present report summarizes the experience on the mar(X) syndrome in a total of 157 male patients (44 prepubertal and 113 postpubertal) ascertained through 83 index patients from 83 families under investigation. In one third of the families pedigree data were consistent with X-linked recessive inheritance. In the further two thirds of the families the presenting symptom was familial mental retardation with a mentally retarded mother, or mental subnormality with hyperkinetic behaviour in the male patient. No more than 60% of the adult males presented the typical clinical triad (mental retardation-long face-megalotestes). The most characteristic finding in the mar(X) boy is the psychological profile with severe hyperkinetism, hypersensitivity, handbiting and autistic features in some of them. In 4 of the 27 large mar(X) pedigrees strong evidence was present of a possible transmission of the mar(X) through normal males. The high incidence of mental subnormality in the female offspring of heterozygote carriers, and the relationship between mental status, phenotype, age and expression of the mar(X) in different culture conditions is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6499265     DOI: 10.1111/j.1399-0004.1984.tb01099.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  22 in total

1.  Fragile X syndrome among children with mental retardation.

Authors:  R Elango; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Sotos syndrome.

Authors:  T R Cole; H E Hughes
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

3.  Chromosomal fragility and human genetic disorders.

Authors:  S Baskaran; V Brahmachari
Journal:  Indian J Clin Biochem       Date:  2000-08

4.  Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

Authors:  R Lane Coffee; Charles R Tessier; Elvin A Woodruff; Kendal Broadie
Journal:  Dis Model Mech       Date:  2010-05-04       Impact factor: 5.758

5.  Recurrent mutation pressure does not explain the prevalence of the marker (X) syndrome.

Authors:  F Vogel; J Krüger; K B Nielsen; J P Fryns; D Schindler; A Schinzel; A Schmidt; E Schwinger
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  The fragile X syndrome in a large family. I. Cytogenetic and clinical investigations.

Authors:  H Veenema; J P Geraedts; G C Beverstock; P L Pearson
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

7.  Linkage analysis using multiple Xq DNA polymorphisms in normal families, families with the fragile X syndrome, and other families with X linked conditions.

Authors:  J M Connor; L A Pirrit; J R Yates; J A Crossley; S J Imrie; J M Colgan
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

8.  Prevalence of the fragile X syndrome in four birth cohorts of children of school age.

Authors:  M Kähkönen; T Alitalo; E Airaksinen; R Matilainen; K Launiala; S Autio; J Leisti
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

9.  A comparison of language characteristics of mentally retarded adults with fragile X syndrome and those with nonspecific mental retardation and autism.

Authors:  R Paul; E Dykens; J F Leckman; M Watson; W R Breg; D J Cohen
Journal:  J Autism Dev Disord       Date:  1987-12

Review 10.  Systematic review of pharmacological treatments in fragile X syndrome.

Authors:  Jose-Ramon Rueda; Javier Ballesteros; Maria-Isabel Tejada
Journal:  BMC Neurol       Date:  2009-10-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.